Premium
Cariprazine in two dose strengths found effective for bipolar depression
Publication year - 2019
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30444
Subject(s) - bipolar disorder , depression (economics) , medicine , psychiatry , depressive symptoms , placebo , antipsychotic , bipolar i disorder , schizophrenia (object oriented programming) , psychology , clinical psychology , anxiety , cognition , alternative medicine , mania , economics , macroeconomics , pathology
The atypical antipsychotic cariprazine was more effective than placebo in improving depressive symptoms in a Phase 3 study involving adults with bipolar disorder and a current depressive episode. Both 1.5 mg/day and 3 mg/day doses of the drug were found to be relatively safe and effective, researchers reported. Study results were published online March 8 in the American Journal of Psychiatry .